Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Snipr Technologies Limited currently manages 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is being reviewed by 1 distinct examiner. The prosecution is localized in 1 distinct art unit, indicating a specific technical focus for the company. GRASER, JENNIFER E is the busiest examiner, holding 1 busiest examiner pending office action. Since the total count of pending office actions is 1, this examiner handles the entirety of the company's active workload.
With 1 pending office action, 1 distinct examiner, and 1 distinct art unit, the prosecution profile is highly concentrated. This allows Snipr Technologies Limited to focus its efforts on the specific examination style of GRASER, JENNIFER E within that 1 distinct art unit. This focus within the Biotechnology & Pharmaceuticals sector allows for a streamlined approach to addressing examiner concerns. By concentrating all activity in the 1 distinct art unit, the company minimizes the need to navigate varying procedural standards across different USPTO departments. The presence of only 1 distinct examiner indicates that the portfolio does not currently face diverse examination styles. Practitioners can focus their strategy on the specific tendencies of the busiest examiner to resolve the 1 pending office action efficiently.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GRASER, JENNIFER E | 1 | 76.8% | +23.2% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19020993 | ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA | GRASER, JENNIFER E | — |
| Art Unit | Apps |
|---|---|
| 1645 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19020993 | ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA | GRASER, JENNIFER E | 1645 | §103DP | Non-Final OA | — | Pending | Jan 14, 2025 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialSnipr Technologies Limited has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Jennifer E Graser has the most, with 1 of Snipr Technologies Limited's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.